pharmaphorum

AI biotechs Exscientia and Recursion agree $688m merger

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
pharmaphorum

Recursion, Exscientia, and AI drug discovery’s moment of truth

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
The New York Times

Silicon Valley Wants to Build A.I. That Can Improve A.I. on Its Own

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...
IEEE

Recursive Slow Feature Analysis for Adaptive Monitoring of Industrial Processes

Abstract: Recently, a new process monitoring and fault diagnosis method based on slow feature analysis has been developed, which enables concurrent monitoring of both operating point and process ...
GitHub

GopherJS - A compiler from Go to JavaScript

GopherJS compiles Go code (go.dev) to pure JavaScript code. Its main purpose is to give you the opportunity to write front-end code in Go which will still run in all browsers. Nearly everything, ...
IEEE

Blockwise Recursive Moore–Penrose Inverse for Network Learning

Abstract: Training neural networks with the Moore–Penrose (MP) inverse has recently gained attention in view of its noniterative training nature. However, a significant drawback of learning based on ...